GLENMARK PHARMACEUTICALS
Back to Cashflow Statement
|
GLENMARK PHARMACEUTICALS Last 5 Year Net Cash Inflow / Outflow History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Net Cash Inflow / Outflow | ₹-547 Cr | ₹-38 Cr | ₹389 Cr | ₹19 Cr | ₹255 Cr |
What is the latest Net Cash Inflow / Outflow ratio of GLENMARK PHARMACEUTICALS ?
| Year | Net Cash Inflow / Outflow |
|---|---|
| Mar2026 | ₹-547 Cr |
| Mar2025 | ₹-38 Cr |
| Mar2024 | ₹389 Cr |
| Mar2023 | ₹19 Cr |
| Mar2022 | ₹255 Cr |
How is Net Cash Inflow / Outflow of GLENMARK PHARMACEUTICALS Trending?
| Years | Net Cash Inflow / Outflow | % Change | |
|---|---|---|---|
| Mar2026 | ₹-547 Cr | Negative | |
| Mar2025 | ₹-38 Cr | Negative | |
| Mar2024 | ₹389 Cr | 1,902.17 | |
| Mar2023 | ₹19 Cr | -92.37 | |
| Mar2022 | ₹255 Cr | - | |
Compare Net Cash Inflow / Outflow of peers of GLENMARK PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| GLENMARK PHARMACEUTICALS | ₹75,488.5 Cr | 7.1% | 17% | 40.5% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹454,914.0 Cr | 7.3% | 8.4% | 13.1% | Stock Analytics | |
| DIVIS LABORATORIES | ₹300,380.0 Cr | 15.3% | 24.1% | 63% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹181,169.0 Cr | 1% | 2.5% | 33.4% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹114,933.0 Cr | 1% | 15.9% | 14% | Stock Analytics | |
| CIPLA | ₹114,478.0 Cr | 0.4% | 7.9% | -6.2% | Stock Analytics | |
GLENMARK PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| GLENMARK PHARMACEUTICALS | 7.1% |
17% |
40.5% |
| SENSEX | 5.9% |
13% |
-1.9% |
You may also like the below Video Courses